This Article Full Text Full Text (PDF) All Versions of this Article: 40/2/492    most recent STROKEAHA.108.516286v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Henneman, W. J.P. Articles by van der Flier, W. M. Search for Related Content PubMed PubMed Citation Articles by Henneman, W. J.P. Articles by van der Flier, W. M. Related Collections CT and MRI Computerized tomography and Magnetic Resonance Imaging

(Stroke. 2009;40:492.)
© 2009 American Heart Association, Inc.

Original Contributions

MRI Biomarkers of Vascular Damage and Atrophy Predicting Mortality in a Memory Clinic Population

Wouter J.P. Henneman, MD; Jasper D. Sluimer, MD; Charlotte Cordonnier, MD; Merel M.E. Baak; Philip Scheltens, PhD; Frederik Barkhof, PhD Wiesje M. van der Flier, PhD

From Alzheimer Center, Department of Neurology (W.J.P.H., J.D.S., C.C., M.M.E.B., P.S., F.B., W.M.v.d.F.) and Department of Radiology (W.J.P.H., J.D.S., F.B.), VU University Medical Center, Amsterdam, The Netherlands; Department of Neurology and Stroke Department (C.C.), Lille University Hospital, France.

Correspondence to W.J.P. Henneman, MD, Department of Radiology and Alzheimer Center, VU University Medical Center, PO Box 7057, 1007 MB Amsterdam, The Netherlands. E-mail w.henneman{at}vumc.nl

Background and Purpose— MRI biomarkers play an important role in the diagnostic work-up of dementia, but their prognostic value is less well-understood. We investigated if simple MRI rating scales predict mortality in a memory clinic population.

Methods— We included 1138 consecutive patients attending our memory clinic. Diagnostic categories were: subjective complaints (n=220), mild cognitive impairment (n=160), Alzheimer disease (n=357), vascular dementia (n=46), other dementia (n=136), and other diagnosis (n=219). Baseline MRIs were assessed using visual rating scales for medial temporal lobe atrophy (range, 0–4), global cortical atrophy (range, 0–3), and white matter hyperintensities (range, 0–3). Number of microbleeds and presence of infarcts were recorded. Cox-regression models were used to calculate the risk of mortality.

Results— Mean follow-up duration was 2.6 (±1.9) years. In unadjusted models, all MRI markers except infarcts predicted mortality. After adjustment for age, sex, and diagnosis, white matter hyperintensities, and microbleeds predicted mortality (white matter hyperintensities: hazard ratio [HR], 1.2; 95% CI, 1.0–1.4; microbleeds: HR, 1.02 95% CI, 1.00–1.03; categorized: HR, 1.5; 95% CI, 1.1–2.0). The predictive effect of global cortical atrophy was restricted to younger subjects (HR, 1.7; 95% CI, 1.2–2.6). An interaction between microbleeds and global cortical atrophy indicated that mortality was especially high in patients with both microbleeds and global cortical atrophy.

Conclusion— Simple MRI biomarkers, in addition to their diagnostic use, have a prognostic value with respect to mortality in a memory clinic population. Microbleeds were the strongest predictor of mortality.

Key Words: dementia • magnetic resonance imaging • microbleeds • mortality • white matter

This article has been cited by other articles:

				S. M. Gregoire, U. J. Chaudhary, M. M. Brown, T. A. Yousry, C. Kallis, H. R. Jager, and D. J. Werring The Microbleed Anatomical Rating Scale (MARS): Reliability of a tool to map brain microbleeds Neurology, November 24, 2009; 73(21): 1759 - 1766. [Abstract] [Full Text] [PDF]